
Sotera Health Grows Revenues 5% to $1.1B Amid Supply and Litigation Risks
Sotera Health CompanyDescription
What this story covers
Sotera Health's 2024 10-K shows 5% revenue growth to $1.1B, driven by pricing and volumes in sterilization and testing. Strong EBITDA margins persist despite capex and debt refinancing. Risks from EO regulations and litigation loom, but vertical integration and expansions support resilience in healthcare services.
Story snapshot
CompanySotera Health Company
TickerSHC
VariantStandard detailed
Duration12:56
Filing type10-K
PeriodAnnual 2024
IndustryHealthcare & Pharmaceuticals
Accession0001822479-25-000015
Full Story Script
Content not available for this story.